HSP90b1 has been identified as a potential molecular carrier for tumor antigens, aiding in tumor antigen presentation and activating CD8 + cytotoxic T lymphocytes, which are crucial for anti-tumor specific immune responses. This evidence concerns the gene CD8A and neoplasm.